FOXO Technologies Unveils Plans For New Direct-to Consumer Offering Combining The Company's Epigenetic Data With The Power Of AI

FOXO Technologies Inc. Class A Common Stock -1.69%

FOXO Technologies Inc. Class A Common Stock

FOXO

0.17

-1.69%

Announces Collaboration and Secures Exclusive License with KR8.ai to Power New Epigenetic Wellness Solutions

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via